Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRYSTAL
2024-517441-14-00Phase 4Authorised
- Sponsor
- CHU Rennes
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in conjunctivitis comparing Hydrocortisone arm with Dexamethasone arm (2 arms). Primary endpoint: Secretion Self-Rating Scale score. Planned start Oct 2024; status: authorised.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
conjunctivitis
Beyond the preview
Go deeper on 2024-517441-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517441-14-00.